Adhesion of the obligate intracellular bacterium Chlamydia trachomatis to host cells is associated with a flux of Cat+ across the cell membrane, and infection is enhanced by treatment of host cells with Cat+ ionophore. The possibility that Cat+ might interact with host cell C a t + regulatory proteins to promote chlamydial infection was investigated. Treatment of HeLa 229 cells with the calmodulin inhibitors pimozide, trifluoperazine, chlorpromazine, promethazine or haloperidol reduced chlamydial infectivity as measured by inclusion counting or the specific incorporation of [3 Hlthreonine. The inhibitory effect was reversible, dose-related and shown to be associated with impairment of chlamydial adhesion and uptake by the host cells. This effect was clearly distinguished from the delayed maturation of chlamydiae due to continuous exposure to calmodulin inhibitors which may result from a decrease in the availability of high energy compounds from the host cells necessary for chlamydial growth. The possible mechanisms for calmodulin-mediated chlamydial endocytosis are discussed.
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Adhesion of the obligate intracellular bacterium Chlamydia trachomatis to host cells is associated with a flux of Cat+ across the cell membrane, and infection is enhanced by treatment of host cells with Cat+ ionophore. The possibility that Cat+ might interact with host cell C a t + regulatory proteins to promote chlamydial infection was investigated. Treatment of HeLa 229 cells with the calmodulin inhibitors pimozide, trifluoperazine, chlorpromazine, promethazine or haloperidol reduced chlamydial infectivity as measured by inclusion counting or the specific incorporation of [3 Hlthreonine. The inhibitory effect was reversible, dose-related and shown to be associated with impairment of chlamydial adhesion and uptake by the host cells. This effect was clearly distinguished from the delayed maturation of chlamydiae due to continuous exposure to calmodulin inhibitors which may result from a decrease in the availability of high energy compounds from the host cells necessary for chlamydial growth. The possible mechanisms for calmodulin-mediated chlamydial endocytosis are discussed.
I N T R O D U C T I O N
Chlamydiae are specialized bacteria of major importance in human and veterinary medicine and characterized by a unique growth cycle within the host cell (Ward, 1983) . Chlamydia1 adherence, internalization and subsequent intracellular growth can be measured readily by selectively radiolabelling chlamydiae with amino acids in the presence of host cell protein synthesis inhibitors (Becker & Asher, 1972; Allan & Pearce, 1982) . Thus chlamydiae are an ideal model for investigating pathogen-host cell interactions.
Infection is initiated by the adhesion of chlamydial elementary bodies to unidentified host cell membrane components followed by rapid uptake. Chlamydiae are endocytosed by HeLa cells 10-100 times faster than polystyrene latex particles or Escherichia coli (Byme & Moulder, 1978) implying that a specialized uptake mechanism exists. Treatment of HeLa cells with ionophore A23187 to promote a Ca2+ flux across the cell membrane stimulates chlamydial infectivity; moreover, centrifugation of chlamydial elementary bodies on to the host cell surface is accompanied by the movement of Cat + across the host cell membrane (Ward & Salari, 1982) . A calcium flux at the host cell membrane might facilitate chlamydial uptake by an increase in cell membrane fluidity following activation of calcium-dependent, host cell membrane phospholipase A? (Weltzien, 1979) or by activation of some other process dependent on calmodulin. Calmodulin is a protein ubiquitously distributed in eukaryotic cells which, with calcium, regulates vital cell functions including cyclic nucleotide catabolism (Weiss & Levin, 1978) , Ca? +-dependent ATPase activity (Corps et al., 1982) , receptor-mediated endocytosis (Salisbury et al., 1981) , phagocytosis (Horowitz et al., 1981) 
M E T H O D S
Materials. Chlamydia trachomatis strains L1/440/LN and L2/434/BU were provided by the Institute of Ophthalmology, London, UK. Reagents were obtained from the following sources: 10-[3-(4-methylpiperazin-1-yl)propyl]-2-trifluoromethylphenothiazine (trifluoperazine ; TFP) was a kind gift from Smith, Kline & French Laboratories, Welwyn Garden City, UK ; 1 -[ 1-(4,4-bis(p-fluorophenyl) butyllpiperid 4-yl benzimidazolin-2-one (pimozide) and y-(4-pchlorphenyl-4-hydroxypiperidine)-pfluorobutyrophenone (haloperidol) from Janssen Pharmaceutical, Marlow, Bucks, UK ; I0-(2-dimethylaminopropyl) phenothiazine (promethazine) from May & Baker, Dagenham, Essex, UK ; 2-chloro-l0-(3-dimethylaminopropyl) phenothiazine (chlorpromazine) from Sigma; A23187 was a gift from Dr R. Hamill, Lilly Research Laboratories, Indianapolis, Ind. 46206, USA. Stock solutions of haloperidol and pimozide were dissolved in ethanol at 10-M; chlorpromazine hydrochloride, trifluoperazine hydrochloride and promethazine were dissolved at 10-M in de-aerated saline buffered at pH 7.2 with 30 mM-HEPES. A23187 was dissolved in DMSO at lo-) M. Solutions were freshly prepared before each experiment and protected from light.
Tissue culture. HeLa 229 cells were grown and maintained free of mycoplasma contamination as previously described (Ward & Salari, 1982) .
Preparation of inocufa. Chlamydiae were grown in McCoy cells in the presence of cycloheximide (1 pg ml-I ), the infected cells ruptured using a Dounce homogenizer (Jencons, London, UK) and the chlamydiae purified by density gradient centrifugation (Salari & Ward, 198 1) . Purified chlamydiae were resuspended in cryoprotective sucrose phosphate buffer consistingof 68.46 g sucrose 2-088 g K2HP0,, 1.088 g K H 2 P 0 4 in 100 ml H 2 0 adjusted to pH 7.2. The number of chlamydial particles in the suspension was counted by dark ground microscopy in a bacterial counting chamber, the inoculum standardized to 4-8 x 1Olo particles ml-I , stored frozen at -196 "C, and the infectivity determined by titration on HeLa 229 cells (Salari & Ward, 1981) .
Determination of chfamydiaf [3H]threonine uptake. The effect of calmodulin inhibitors and other treatments on the infectivity of chlamydiae for HeLa 229 cells was determined by measuring chlamydial amino acid uptake as previously described (Ward & Salari, 1982) but utilizing ~~-[~H ] t h r e o n i n e (Amersham) at 2 pCi ml-' (74 kBq ml-I ) in threonine-deficient Dulbecco's minimal essential medium (TD-DMEM). Controls routinely included uninfected cells with and without emetine to confirm that host cell protein synthesis was inhibited, and emetine-treated uninfected cells with the test agent to ensure that the agent was not cytotoxic. In addition, cytotoxicity was monitored by microscopic examination of HeLa cell monolayers after treatment with the test compound. Monolayer cells were washed, solubilized in 1 % (w/v) SDS in 0.1 M-NaOH and their radioactivity determined by liquid scintillation counting with a counting efficiency of 55 %.
Threonine uptake by uninfected cells in the presence of emetine was typically 10-20% of the uptake of infected cells (Fig. I ). This background value was subtracted to give the chlamydial-dependent threonine uptake. Some 90% of the [)HIthreonine incorporated by chlamydiae could be recovered by precipitation with cold 5% (w/v) TCA. This chlamydial threonine incorporation was abolished by the addition of the antichlamydial agent rifampicin (Sigma) at 1 pg ml-I to infected cultures immediately after challenge.
Inclusion counting. Chlamydia1 infected HeLa cell monolayers were fixed in I % (v/v) glutaraldehyde in 0.1 Mcacodylate, pH 7.2, and counted by interference or phase contrast microscopy. This method was much simpler than Giemsa staining; chlamydial inclusions could be identified readily both morphologically and by the Brownian movement of chlamydial particles within the cell as early as 22 h after infection. The number of infected and uninfected cells in a minimum of 10 microscope fields was determined as previously described (Ward & Salari, 1982) .
Preparation of radiolabelfed chlamydiae. Confluent monolayers of HeLa 229 cells in 400 ml volume glass tissue culture bottles were inoculated with 10 ml TD-DMEM containing 1 pg ml-I emetine hydrochloride and purified C. trachomatis was added to achieve infection in 90% of the cells. After 4.5 h incubation at 36 "C to permit chlamydial adsorption, 10 ml medium was added to each bottle and after further incubation for 18 h, 160 pl DL-[) Hlthreonine containing 160 pCi (5.92 MBq) was added. After a further 2 4 4 8 h incubation the cells were washed in PBS (Dulbecco A; Oxoid), the cells detached by brief treatment with 0.125% (w/v) trypsin (Flow Laboratories) in PBS at 36 "C, collected in DMEM containing 10% (v/v) foetal calf serum and sedimented at 200g for 5 min at 0 "C. Cells were ruptured with a Dounce homogenizer and radiolabelled chlamydiae were separated from the host cell debris by trios11 density gradient centrifugation (Salari & Ward, 1981) and stored frozen at -196 "C in sucrose/phosphate buffer. A typical batch of chlamydiae labelled by this method contained 2.5 x 10") chlamydiae and 2.8 x lo5 c.p.m. m1-I.
Measurement of chfamydiaf attachment. Adhesion of chlamydiae to TFP-treated (test) and untreated (control) cells was compared. HeLa 229 cells were grown overnight in DMEM to lightly confluent monolayers on glass coverslips (approx. 5 x lo5 cells) in 24-well polystyrene tissue culture trays. Test cells were treated for 2.5 h at 36°C with ~O~M -T F P in DMEM whilst control cells were incubated for the same period in DMEM. The supernatant tissue culture medium was removed and 200 pI DMEM buffered with 30 mM-HEPES pH 7.2 containing 3000 c.p.m. radiolabelled C. trachomatis LGV 440 and 30 ~M -T F P as appropriate was added to each well. After gentle rocking at 37 "C to promote attachment, the coverslips were washed thoroughly with HBSS at room temperature and removed to a fresh 24-well tissue culture tray. Cell-associated chlamydiae were solubilized in 1 % SDS in 0.1 M-NaOH and the radioactivity determined by liquid scintillation counting.
Measurement of chlamydial uptake. The method used was a modification of the method of Byrne (1978) and is based on the observations that chlamydial uptake but not adhesion is prevented at low temperature and that adherent chlamydiae, unlike intracellular chlamydiae, can be removed from the host cell surface by trypsinization. HeLa 229 cells were grown overnight to light confluence in 24-well tissue culture trays then treated for 1 h at 36 "C with different concentrations of TFP in DMEM. The medium in each well was replaced with 5 0 0 4 of a suspension of 3H-labelled C. rrachornaris LGV 434 in ice-cold DMEM buffered at pH 7.2 with 30 mM-HEPES and containing some 6OOO c.p.m. 3H per well. The radiolabelled chlamydiae were centrifuged on to the host cells for 1 h at lo00 g, 8 "C, and the medium was replaced with 1 ml of HEPES-buffered ice-cold DMEM. The trays were rapidly warmed to 36 "C by flotation in a water bath and incubated for 30 min to permit chlamydial uptake. After washing in ice-cold PBS, 125 plO.125% trypsin (Flow Laboratories) and 0.01 % EDTA in PBS was added to each well and the plates incubated at 36 "C for 10 min. To each well 75 p1 ice-cold HBSS containing 20% foetal calf serum was added to inactivate the trypsin and the cells were carefully resuspended and transferred to an ice-cooled 96-well U-bottom microtitration tray. The tray was centrifuged for 5 min at lOOg, 4 "C, the supernatant medium aspirated, the cell pellet solubilized in 150 pI 1 % SDS in 0.1 M-NaOH and the radioactivity due to intracellular chlamydiae determined. Preliminary experiments established that under these conditions uptake was complete after 30 min. The trypsin-EDTA treatment selected was optimal for the removal of cell surface adherent chlamydiae: after centrifugation on to the host cell surface for 1 h at 8 "C all but 6% of the radioactivity due to adherent chlamydiae was removed by trypsinization. The residual counts were attributed to chlamydiae inevitably internalized as the cells were warmed to 36 "C for enzyme digestion and were subtracted from the data in Fig. 5 .
Electron microscopy. Cell monolayers adherent to 24-well tissue culture trays were fixed at 0 "C in 1% glutaraldehyde in 0.1 M-CaCodylate buffer pH 7-2, post-fixed in osmium tetroxide and uranyl acetate then dehydrated in ethanol. The dehydrated cell monolayer was removed intact from its polystyrene substratum by brief treatment with 2-epoxy propane (BDH) and flat-embedded in Spurr low viscosity epoxy resin (Taab Laboratories, Reading, UK). This method effectively preserved the in siru arrangement of the cell monolayers in the tissue culture tray. Preparations were sectioned with a diamond knife, stained with Reynolds lead citrate and examined with a Philips EM 300 transmission electron microscope.
RESULTS

Relationship between chlamydial threonine uptake and infectivity
Replicate (1 2) monolayers of HeLa 229 cells were challenged with different numbers of chlamydiae, and the incorporation of [3H]threonine by the infected cells measured 42 h after challenge (Fig. 1) . SDS for the replicate samples over a wide range of chlamydial inocula varied between 3-7 % of the sample mean, permitting regression analysis by the least squares method.
The relationship between chlamydial infectivity and threonine uptake was curvilinear implying that as the inoculum increased the proportion of cells infected also increased but the probability that a given elementary body would infect a hitherto uninfected cell decreased, particularly at a ch1amydiae:cell ratio in excess of 100. Between the limits of 20-100 chlamydial particles inoculated per cell, small changes in chlamydial numbers produced significant changes in
[3H]threonine uptake with P < 0.01 for the sample means tested against each other using a 1-tail t test (Cooke et al., 1982) .
Effect of calmodulin inhibitors on chlamydial infectivity
HeLa 229 cell monolayers were incubated with a range of concentrations of each of five different calmodulin inhibitors for 1 h before chlamydial inoculation. These concentrations were maintained on the cells throughout the subsequent chlamydial challenge and incubation. Chlamydia1 [3H]threonine uptake was determined 42 h after inoculation (Fig. 2) . Pimozide, TFP and chlorpromazine were potent inhibitors of chlamydial growth in HeLa cells; the concentration of drug required to inhibit chlamydial threonine uptake by 50% being 5, 7 and 1 1 VM, respectively. Haloperidol and promethazine were less active, the corresponding inhibitory concentrations being 45 and 47 VM. Low concentrations (5 p~) of haloperidol and promethazine caused a small increase in threonine uptake by both infected and uninfected cells, the reasons for which are unknown. Inclusion counting and transmission electron micrographs of the infected cells confirmed that the calmodulin inhibitors produced not only a marked reduction in the number of inclusions but also a reduction in the number of mature, infectious elementary bodies within the inclusions (Fig. 3) .
A . M U R R A Y A N D M . E . W A R D
Eflect of timing of TFP addition on the chlamydial growth cycle
To determine which stages of the chlamydial growth cycle were susceptible to inhibition by TFP the effects of long term and short term TFP treatment were determined. Replicate monolayer cultures of HeLa 229 cells in 24-well trays were infected at time zero with C. trachomatis LGV 434. At 2 h before inoculation (pre-treatment), at inoculation or at 2, 22 and 34 h after inoculation, 10 p1 concentrated TFP (2 x p~) was added to the tissue culture medium so as to achieve a final concentration of 20 p~. The TFP was maintained on the cells until the chlamydial [3H]threonine uptake was determined 42 h after challenge. The inhibitory effect of TFP on chlamydial threonine uptake increased with the duration of treatment (Table 1) .
To establish if this effect was reversible, the experiment was repeated but the inhibitor was added for only 2 h periods at different points in the chlamydial growth cycle. The results of this treatment on chlamydial threonine uptake and on the number of chlamydial inclusions are shown in Table 2 . In seven different experiments TFP treatment was always maximally effective when added at the time of chlamydial challenge, significantly reducing chlamydial inclusion counts compared with the untreated control (P < 0.01, 1-tail t test) and reducing chlamydial threonine uptake by 30-50% (Table 2) . * Mean (k95% confidence interval for the mean) of four replicate counts, 40 h after challenge.
t Mean (&95% confidence interval for the mean) of the number of inclusions in 10 fields. Table 3 . Effect of incubating chlamydiae with high concentrations of TFP A concentrated inoculum of C. truchomutis LGV 440 was incubated for 2 h at 36 "C with the indicated concentration then diluted 20-fold and its infectivity for HeLa cells determined by measuring chlamydial threonine uptake.
Concentration of TFP Final concentration Mean chlamydial in incubation with
of TFP on HeLa 229 threonine uptake chlamydiae ( p~) cells ( t Probability on a 1-tail t test that threonine incorporation by TFP-treated chlamydiae is less than in the untreated control.
To exclude the possibility that the inhibitory effect of TFP at chlamydial challenge might have been due to a direct toxic action of the compound on chlamydiae, a concentrated chlamydial inoculum was incubated for 2 h at 36 "C with tissue culture medium with(test) or without various concentrations of TFP. The chlamydiae were then diluted 20-fold and their infectivity for HeLa 229 cells assayed. Incubation of chlamydiae with TFP up to 80 PM caused no statistically significant decrease in chlamydial [3 Hlthreonine uptake (Table 3 ). Only after incubation in 100 ~M -T F P was there a significant decrease in chlamydial infectivity ( P < 0-05) and this was entirely attributable to the residual 5 PM-TFP incubated with the host cells after dilution of the treated inoculum. Thus there was not evidence that TFP at much higher concentrations than those used in this study was directly toxic to chlamydiae. ESfect of TFP on chlamydial adhesion and uptake When the adhesion of radiolabelled, purified C. trachomatis to TFP treated (test) or untreated (control) HeLa cells was compared it was found that 20 or 30 ~M -T F P inhibited adhesion of chlamydiae to the host cell (Fig. 4) . In a separate experiment to determine the effect of TFP on chlamydial uptake, radiolabelled chlamydiae were centrifuged for 1 h at 1000 g, 8 "C, on to the host cell surface, non-adherent chlamydiae removed and the cells rapidly warmed to 36 "C for 30 min to initiate uptake. The cell monolayers were then washed, treated with trypsin-EDTA to remove surface-adherent chlamydiae, and, following centrifugation, the radioactivity in the cell pellet attributable to interiorized chlamydiae was determined. The experiment was repeated three times and Fig. 5 shows a typical result. TFP markedly decreased chlamydial uptake, and this effect was linearly dependent on the concentration of inhibitor over the range 5-30 p~.
DISCUSSION
The calmodulin inhibitors TFP, chlorpromazine and promethazine are phenothiazines ; pimozide is a diphenylbutylpiperidine and haloperidol is a butyrophenone. All of these structurally diverse compounds inhibited HeLa cell susceptibility to chlamydial infection with pimozide the most active compound followed in order by TFP, chlorpromazine, haloperidol and promethazine. This paralleled the ability of these compounds to inhibit calmodulin-dependent, Ca2 +-mediated activation of cyclic nucleotide phosphodiesterase in cell-free systems which was determined by the relative affinity of the inhibitors for the hydrophobic binding site on calmodulin (Weiss et al., 1980) . TFP was shown not to have a direct toxic action on chlamydiae and this together with the failure of others to detect calmodulin-like compounds in prokaryotic organisms (Means et af., 1982) implies that the inhibitory action of TFP was mediated via host cell calmodulin.
Calmodulin inhibitors had two clearly distinguished effects on the chlamydial-host cell interaction. Short term (2 h) treatment with TFP at or immediately prior to chlamydial challenge reduced chlamydial infectivity as shown by a reduction in the number but not the size of inclusions with an associated reduction in chlamydial growth as measured by threonine uptake. Similar treatment after chlamydial challenge and adsorption had no effect. This short term effect of TFP was due to a reduction in both adhesion to and subsequent uptake of chlamydiae by the host cell. Continuous treatment with calmodulin inhibitors resulted in a reduction in the size and maturity of inclusions, which was most marked for pimozide and was related to the length of treatment. Calmodulin inhibitors are known to impair mitochondria1 energy production and the adenylate energy charge of cells, presumably due to their inhibitory effect on the calmodulin-regulated Ca2 +-dependent ATPase (Corps et af., 1982) . Chlamydiae are dependent on the host cell for their supply of high energy compounds so such an effect would inevitably impair their maturation.
Data presented in this paper suggest that chlamydiae enter cells by a calmodulin-dependent process. Identification of the critical sites of calmodulin involvement requires a much more detailed understanding of the mechanisms of chlamydial endocytosis. The approach used here of selectively inhibiting host cell functions has provided important insight into the mechanisms by which viruses such as Semliki forest, vesicular stomatitis and Sindbis enter host cells. These viruses enter host cells in a clathrin-coated vesicle as part of the normal process of receptormediated endocytosis which is independent of host cell microfilaments (Marsh & Helenius, 1980; Schlegel et af., 1982; Talbot & Vance, 1982) . Calmodulin is a major component of clathrincoated vesicles (Aggeler & Werb, 1982) but the role of calmodulin in viral uptake is unknown. Chlamydia1 particles are much larger than these viruses and on the grounds of size alone might be expected to enter cells by micofilament-dependent phagocytosis (Silverman et af., 1977) . Although chlamydial endocytosis is unaffected by the microfilament inhibitor cytochalasin B (Sompolinski & Richmond, 1974; Gregory et al., 1979) more recent work suggests cytochalasininhibited microfilaments are still capable of endocytosing small particles the size of chlamydiae (Painter et al., 1981) . Calmodulin inhibitors might interfere with such a process by blocking the calmodulin-dependent activation of myosin light chain kinase required for microfilament contraction (Salisbury et af., 1981) . In addition TFP might block chlamydial endocytosis by reducing the recruitment of clathrin to the cell surface which is essential to both receptormediated endocytosis and phagocytosis for the recycling of endocytosed membrane (Aggeler & Werb, 1982) ; Salisbury et af., 1980). Finally calmodulin inhibitors are hydrophobic compounds which bind to host cell surfaces reducing membrane fluidity (Norman, 1980; Kanaho et al., 1982) and perhaps indirectly impairing chlamydial endocytosis.
